Cargando…
Baroreflex sensitivity in facioscapulohumeral muscular dystrophy
Facioscapulohumeral muscular dystrophy (FSHD), a common form of muscular dystrophy, is caused by a genetic mutation that alters DUX4 gene expression. This mutation contributes to significant skeletal muscle loss. Although it is suggested that cardiac muscle may be spared, people with FSHD have demon...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023871/ https://www.ncbi.nlm.nih.gov/pubmed/35451178 http://dx.doi.org/10.14814/phy2.15277 |
_version_ | 1784690435060400128 |
---|---|
author | Anselmo, Miguel Coffman, Shandon Larson, Mia Vera, Kathryn Lee, Emma McConville, Mary Kyba, Michael Keller‐Ross, Manda L. |
author_facet | Anselmo, Miguel Coffman, Shandon Larson, Mia Vera, Kathryn Lee, Emma McConville, Mary Kyba, Michael Keller‐Ross, Manda L. |
author_sort | Anselmo, Miguel |
collection | PubMed |
description | Facioscapulohumeral muscular dystrophy (FSHD), a common form of muscular dystrophy, is caused by a genetic mutation that alters DUX4 gene expression. This mutation contributes to significant skeletal muscle loss. Although it is suggested that cardiac muscle may be spared, people with FSHD have demonstrated autonomic dysregulation. It is unknown if baroreflex function, an important regulator of blood pressure (BP), is impaired in people with FSHD. We examined if baroreflex sensitivity (BRS) is blunted in patients with FSHD. Thirty minutes of resting BP, heart rate, and cardiovagal BRS were measured in 13 patients with FSHD (age: 50 ± 13 years, avg ± SD) and 17 sex‐ and age‐matched controls (age: 47 ± 14 years, p > 0.05). People with FSHD were less active (Activity Metabolic Index, AMI) (FSHD: 24 ± 30; controls: 222 ± 175 kcal/day; p < 0.001) but had a similar body mass index compared with controls (FSHD: 27 ± 4; controls: 27 ± 4 kg/m(2); p > 0.05). BRSup (hypertensive response), BRSdown (hypotensive response), and total BRS were similar between groups (BRSup: FSHD: 12 ± 8; controls: 12 ± 5 ms/mmHg; BRSdown: FSHD: 10 ± 4; controls: 13 ± 6 ms/mmHg; BRS: FSHD: 14 ± 9; controls: 13 ± 6 ms/mmHg; p > 0.05). Mean arterial pressure was similar between groups (FSHD: 96 ± 7; controls: 91 ± 6mmHg). Individuals with FSHD had an elevated heart rate compared with controls (FSHD: 65 ± 8; controls: 59 ± 8 BPM; p = 0.03), but when co‐varied for AMI, this relationship disappeared (p = 0.39). These findings suggest that BRS is not attenuated in people with FSHD, but an elevated heart rate may be due to low physical activity levels, a potential consequence of limited mobility. |
format | Online Article Text |
id | pubmed-9023871 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-90238712022-04-25 Baroreflex sensitivity in facioscapulohumeral muscular dystrophy Anselmo, Miguel Coffman, Shandon Larson, Mia Vera, Kathryn Lee, Emma McConville, Mary Kyba, Michael Keller‐Ross, Manda L. Physiol Rep Original Articles Facioscapulohumeral muscular dystrophy (FSHD), a common form of muscular dystrophy, is caused by a genetic mutation that alters DUX4 gene expression. This mutation contributes to significant skeletal muscle loss. Although it is suggested that cardiac muscle may be spared, people with FSHD have demonstrated autonomic dysregulation. It is unknown if baroreflex function, an important regulator of blood pressure (BP), is impaired in people with FSHD. We examined if baroreflex sensitivity (BRS) is blunted in patients with FSHD. Thirty minutes of resting BP, heart rate, and cardiovagal BRS were measured in 13 patients with FSHD (age: 50 ± 13 years, avg ± SD) and 17 sex‐ and age‐matched controls (age: 47 ± 14 years, p > 0.05). People with FSHD were less active (Activity Metabolic Index, AMI) (FSHD: 24 ± 30; controls: 222 ± 175 kcal/day; p < 0.001) but had a similar body mass index compared with controls (FSHD: 27 ± 4; controls: 27 ± 4 kg/m(2); p > 0.05). BRSup (hypertensive response), BRSdown (hypotensive response), and total BRS were similar between groups (BRSup: FSHD: 12 ± 8; controls: 12 ± 5 ms/mmHg; BRSdown: FSHD: 10 ± 4; controls: 13 ± 6 ms/mmHg; BRS: FSHD: 14 ± 9; controls: 13 ± 6 ms/mmHg; p > 0.05). Mean arterial pressure was similar between groups (FSHD: 96 ± 7; controls: 91 ± 6mmHg). Individuals with FSHD had an elevated heart rate compared with controls (FSHD: 65 ± 8; controls: 59 ± 8 BPM; p = 0.03), but when co‐varied for AMI, this relationship disappeared (p = 0.39). These findings suggest that BRS is not attenuated in people with FSHD, but an elevated heart rate may be due to low physical activity levels, a potential consequence of limited mobility. John Wiley and Sons Inc. 2022-04-21 /pmc/articles/PMC9023871/ /pubmed/35451178 http://dx.doi.org/10.14814/phy2.15277 Text en © 2022 The Authors. Physiological Reports published by Wiley Periodicals LLC on behalf of The Physiological Society and the American Physiological Society https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Anselmo, Miguel Coffman, Shandon Larson, Mia Vera, Kathryn Lee, Emma McConville, Mary Kyba, Michael Keller‐Ross, Manda L. Baroreflex sensitivity in facioscapulohumeral muscular dystrophy |
title | Baroreflex sensitivity in facioscapulohumeral muscular dystrophy |
title_full | Baroreflex sensitivity in facioscapulohumeral muscular dystrophy |
title_fullStr | Baroreflex sensitivity in facioscapulohumeral muscular dystrophy |
title_full_unstemmed | Baroreflex sensitivity in facioscapulohumeral muscular dystrophy |
title_short | Baroreflex sensitivity in facioscapulohumeral muscular dystrophy |
title_sort | baroreflex sensitivity in facioscapulohumeral muscular dystrophy |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023871/ https://www.ncbi.nlm.nih.gov/pubmed/35451178 http://dx.doi.org/10.14814/phy2.15277 |
work_keys_str_mv | AT anselmomiguel baroreflexsensitivityinfacioscapulohumeralmusculardystrophy AT coffmanshandon baroreflexsensitivityinfacioscapulohumeralmusculardystrophy AT larsonmia baroreflexsensitivityinfacioscapulohumeralmusculardystrophy AT verakathryn baroreflexsensitivityinfacioscapulohumeralmusculardystrophy AT leeemma baroreflexsensitivityinfacioscapulohumeralmusculardystrophy AT mcconvillemary baroreflexsensitivityinfacioscapulohumeralmusculardystrophy AT kybamichael baroreflexsensitivityinfacioscapulohumeralmusculardystrophy AT kellerrossmandal baroreflexsensitivityinfacioscapulohumeralmusculardystrophy |